新生児スクリーニングのグローバル市場(2021~2031):器具、消耗品

■ 英語タイトル:Newborn Screening Market By Product Type (Instrument, Consumables), By Test Type (Blood test, Hearing screening test, Heart screening), By Technology (Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Others), By End User (Hospitals, Clinical laboratories): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD22AU201)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD22AU201
■ 発行日:2022年5月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:220
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥853,812見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD10,995 ⇒換算¥1,627,260見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[新生児スクリーニングのグローバル市場(2021~2031):器具、消耗品]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社は、2021年に1,055.24百万ドルであった世界の新生児スクリーニング市場が、2022年から2031年まで年平均6.8%成長し、2031年までに 2,038.47百万ドルに達すると予測しています。当書では、新生児スクリーニングの世界市場を対象に総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、製品タイプ別(器具、消耗品)分析、検査タイプ別(血液検査、聴力スクリーニング検査、心臓スクリーニング)分析、技術別(タンデム質量分析(TMS)、分子アッセイ、免疫測定法&酵素アッセイ、聴力スクリーン技術、パルスオキシメトリースクリーニング技術)分析、エンドユーザー別(病院、臨床検査室)分析、地域別分析、企業状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Ab Sciex LLC、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、Covidien Plc、Ge Healthcare、PERKINELMER, INC.、MASIMO CORPORATION、Natus Medical Incorporated、Trivitron Healthcare、Waters Corporationなどが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の新生児スクリーニング市場規模:製品タイプ別(器具、消耗品)
・世界の新生児スクリーニング市場規模:検査タイプ別(血液検査、聴力スクリーニング検査、心臓スクリーニング)
・世界の新生児スクリーニング市場規模:技術別(タンデム質量分析(TMS)、分子アッセイ、免疫測定法&酵素アッセイ、聴力スクリーン技術、パルスオキシメトリースクリーニング技術)
・世界の新生児スクリーニング市場規模:エンドユーザー別(病院、臨床検査室)
・世界の新生児スクリーニング市場規模:地域別
・企業状況
・企業情報

The global newborn screening market valued at $ 1,055.24 million in 2021, and is projected to reach $ 2,038.47 million by 2031, registering a CAGR of 6.8% from 2022 to 2031.
Newborn screening test is the series of test performed during the first few days of your baby’s life, usually by a hospital health care practitioner. A few drops of blood from a heel prick are placed on a special card, called a Guthrie card. this card, along with your baby’s details, is mailed to a specialized state laboratory, which will test the blood sample for a variety of health disorders, including CF (cystic fibrosis). Newborn screening in certain states requires two blood samples, one at birth and the other a few weeks later. Newborn screening is essential for detection and early diagnosis of certain genetic, endocrine, and metabolic disorders, and are also tested for hearing loss and critical congenital heart defects (CCHDs).
The major factors that drive the growth of the global newborn screening market include increasing government support for newborn screening and development in screening technology. In addition, high birth rate and increasing incidence of neonatal disease propel the market growth. However, lack of improvement in healthcare infrastructure.  Conversely, screening of genetic disorders and emerging market such as Brazil, China and India provide significant opportunities to key players in this market due to increase in birth rates and rise in disposable income.

The global newborn screening market is segmented into  test type, technology , product type and region. According to test type, the market is categorized into  blood  test, hearing screening test,  heart screening test. By technology, it is segregated into tandem mass spectrometry (TMS), molecular assay, immunoassays & enzymatic assays, hearing screen technology, pulse oximetry screening technology and others(DNA based assay and electrophoresis). on the basis of end user, the market is bifurcated into hospitals and clinical laboratories.  Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include the Ab Sciex LLC (subsidiary of Danaher Corporation), Perkinelmer, Inc., Waters Corporation, Natus Medical Incorporated, Masimo Corporation, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Covidien Plc, Ge Healthcare (subsidiary of General Electric Company) and Trivitron Healthcare.
 
Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the newborn screening market analysis from 2021 to 2031 to identify the prevailing Newborn Screening Market opportunity.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the newborn screening market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global newborn screening market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type
● Instrument
● Consumables

By Test Type
● Blood test
● Hearing screening test
● Heart screening

By Technology
● Tandem Mass Spectrometry (TMS)
● Molecular Assays
● Immunoassays and Enzymatic Assays
● Hearing Screen Technology
● Pulse Oximetry Screening Technology
● Others

By End User
● Hospitals
● Clinical laboratories

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ Italy
○ Spain
○ Rest of Europe
○ France
○ U.K.
● Asia-Pacific
○ Japan
○ China
○ Australia
○ India
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ Ab Sciex LLC
○ Agilent Technologies Inc.
○ Bio-Rad Laboratories Inc.
○ Covidien Plc
○ Ge Healthcare
○ PERKINELMER, INC.
○ MASIMO CORPORATION
○ Natus Medical Incorporated
○ Trivitron Healthcare
○ Waters Corporation

*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: NEWBORN SCREENING MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Instrument
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Consumables
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: NEWBORN SCREENING MARKET, BY TEST TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Blood test
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Hearing screening test
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Heart screening
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NEWBORN SCREENING MARKET, BY TECHNOLOGY
6.1 Overview
6.1.1 Market size and forecast
6.2 Tandem Mass Spectrometry (TMS)
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Molecular Assays
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Immunoassays and Enzymatic Assays
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Hearing Screen Technology
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Pulse Oximetry Screening Technology
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
6.7 Others
6.7.1 Key market trends, growth factors and opportunities
6.7.2 Market size and forecast, by region
6.7.3 Market analysis by country
CHAPTER 7: NEWBORN SCREENING MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Clinical laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
CHAPTER 8: NEWBORN SCREENING MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product Type
8.2.3 North America Market size and forecast, by Test Type
8.2.4 North America Market size and forecast, by Technology
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product Type
8.2.6.1.2 Market size and forecast, by Test Type
8.2.6.1.3 Market size and forecast, by Technology
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product Type
8.2.6.2.2 Market size and forecast, by Test Type
8.2.6.2.3 Market size and forecast, by Technology
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product Type
8.2.6.3.2 Market size and forecast, by Test Type
8.2.6.3.3 Market size and forecast, by Technology
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product Type
8.3.3 Europe Market size and forecast, by Test Type
8.3.4 Europe Market size and forecast, by Technology
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product Type
8.3.6.1.2 Market size and forecast, by Test Type
8.3.6.1.3 Market size and forecast, by Technology
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product Type
8.3.6.2.2 Market size and forecast, by Test Type
8.3.6.2.3 Market size and forecast, by Technology
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Product Type
8.3.6.3.2 Market size and forecast, by Test Type
8.3.6.3.3 Market size and forecast, by Technology
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product Type
8.3.6.4.2 Market size and forecast, by Test Type
8.3.6.4.3 Market size and forecast, by Technology
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product Type
8.3.6.5.2 Market size and forecast, by Test Type
8.3.6.5.3 Market size and forecast, by Technology
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product Type
8.3.6.6.2 Market size and forecast, by Test Type
8.3.6.6.3 Market size and forecast, by Technology
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product Type
8.4.3 Asia-Pacific Market size and forecast, by Test Type
8.4.4 Asia-Pacific Market size and forecast, by Technology
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product Type
8.4.6.1.2 Market size and forecast, by Test Type
8.4.6.1.3 Market size and forecast, by Technology
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product Type
8.4.6.2.2 Market size and forecast, by Test Type
8.4.6.2.3 Market size and forecast, by Technology
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Product Type
8.4.6.3.2 Market size and forecast, by Test Type
8.4.6.3.3 Market size and forecast, by Technology
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Product Type
8.4.6.4.2 Market size and forecast, by Test Type
8.4.6.4.3 Market size and forecast, by Technology
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product Type
8.4.6.5.2 Market size and forecast, by Test Type
8.4.6.5.3 Market size and forecast, by Technology
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product Type
8.4.6.6.2 Market size and forecast, by Test Type
8.4.6.6.3 Market size and forecast, by Technology
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product Type
8.5.3 LAMEA Market size and forecast, by Test Type
8.5.4 LAMEA Market size and forecast, by Technology
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product Type
8.5.6.1.2 Market size and forecast, by Test Type
8.5.6.1.3 Market size and forecast, by Technology
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product Type
8.5.6.2.2 Market size and forecast, by Test Type
8.5.6.2.3 Market size and forecast, by Technology
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product Type
8.5.6.3.2 Market size and forecast, by Test Type
8.5.6.3.3 Market size and forecast, by Technology
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product Type
8.5.6.4.2 Market size and forecast, by Test Type
8.5.6.4.3 Market size and forecast, by Technology
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Ab Sciex LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Agilent Technologies Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Bio-Rad Laboratories Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Covidien Plc
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Ge Healthcare
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 PERKINELMER, INC.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 MASIMO CORPORATION
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Natus Medical Incorporated
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Trivitron Healthcare
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Waters Corporation
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 2. NEWBORN SCREENING MARKET REVENUE, FOR INSTRUMENT, BY REGION , 2021-2031,($MILLION)
TABLE 3. NEWBORN SCREENING MARKET FOR INSTRUMENT BY COUNTRY, 2021-2031,($MILLION)
TABLE 4. NEWBORN SCREENING MARKET REVENUE, FOR CONSUMABLES, BY REGION , 2021-2031,($MILLION)
TABLE 5. NEWBORN SCREENING MARKET FOR CONSUMABLES BY COUNTRY, 2021-2031,($MILLION)
TABLE 6. GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 7. NEWBORN SCREENING MARKET REVENUE, FOR BLOOD TEST, BY REGION , 2021-2031,($MILLION)
TABLE 8. NEWBORN SCREENING MARKET FOR BLOOD TEST BY COUNTRY, 2021-2031,($MILLION)
TABLE 9. NEWBORN SCREENING MARKET REVENUE, FOR HEARING SCREENING TEST, BY REGION , 2021-2031,($MILLION)
TABLE 10. NEWBORN SCREENING MARKET FOR HEARING SCREENING TEST BY COUNTRY, 2021-2031,($MILLION)
TABLE 11. NEWBORN SCREENING MARKET REVENUE, FOR HEART SCREENING, BY REGION , 2021-2031,($MILLION)
TABLE 12. NEWBORN SCREENING MARKET FOR HEART SCREENING BY COUNTRY, 2021-2031,($MILLION)
TABLE 13. GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 14. NEWBORN SCREENING MARKET REVENUE, FOR TANDEM MASS SPECTROMETRY (TMS), BY REGION , 2021-2031,($MILLION)
TABLE 15. NEWBORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY (TMS) BY COUNTRY, 2021-2031,($MILLION)
TABLE 16. NEWBORN SCREENING MARKET REVENUE, FOR MOLECULAR ASSAYS, BY REGION , 2021-2031,($MILLION)
TABLE 17. NEWBORN SCREENING MARKET FOR MOLECULAR ASSAYS BY COUNTRY, 2021-2031,($MILLION)
TABLE 18. NEWBORN SCREENING MARKET REVENUE, FOR IMMUNOASSAYS AND ENZYMATIC ASSAYS, BY REGION , 2021-2031,($MILLION)
TABLE 19. NEWBORN SCREENING MARKET FOR IMMUNOASSAYS AND ENZYMATIC ASSAYS BY COUNTRY, 2021-2031,($MILLION)
TABLE 20. NEWBORN SCREENING MARKET REVENUE, FOR HEARING SCREEN TECHNOLOGY, BY REGION , 2021-2031,($MILLION)
TABLE 21. NEWBORN SCREENING MARKET FOR HEARING SCREEN TECHNOLOGY BY COUNTRY, 2021-2031,($MILLION)
TABLE 22. NEWBORN SCREENING MARKET REVENUE, FOR PULSE OXIMETRY SCREENING TECHNOLOGY, BY REGION , 2021-2031,($MILLION)
TABLE 23. NEWBORN SCREENING MARKET FOR PULSE OXIMETRY SCREENING TECHNOLOGY BY COUNTRY, 2021-2031,($MILLION)
TABLE 24. NEWBORN SCREENING MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
TABLE 25. NEWBORN SCREENING MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 26. GLOBAL NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 27. NEWBORN SCREENING MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
TABLE 28. NEWBORN SCREENING MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
TABLE 29. NEWBORN SCREENING MARKET REVENUE, FOR CLINICAL LABORATORIES, BY REGION , 2021-2031,($MILLION)
TABLE 30. NEWBORN SCREENING MARKET FOR CLINICAL LABORATORIES BY COUNTRY, 2021-2031,($MILLION)
TABLE 31. NEWBORN SCREENING MARKET, BY REGION, 2021-2031,($MILLION)
TABLE 32. NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 33. NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 34. NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 35. NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 36. NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 37. U.S. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 38. U.S. NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 39. U.S. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 40. U.S. NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 41. CANADA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 42. CANADA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 43. CANADA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 44. CANADA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 45. MEXICO NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 46. MEXICO NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 47. MEXICO NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 48. MEXICO NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 49. EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 50. EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 51. EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 52. EUROPE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 53. EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 54. GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 55. GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 56. GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 57. GERMANY NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 58. FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 59. FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 60. FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 61. FRANCE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 62. U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 63. U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 64. U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 65. U.K. NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 66. ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 67. ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 68. ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 69. ITALY NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 70. SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 71. SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 72. SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 73. SPAIN NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 74. REST OF EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 75. REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 76. REST OF EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 77. REST OF EUROPE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 78. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 79. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 80. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 81. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 82. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 83. JAPAN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 84. JAPAN NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 85. JAPAN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 86. JAPAN NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 87. CHINA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 88. CHINA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 89. CHINA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 90. CHINA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 91. AUSTRALIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 92. AUSTRALIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 93. AUSTRALIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 94. AUSTRALIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 95. INDIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 96. INDIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 97. INDIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 98. INDIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 99. SOUTH KOREA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 100. SOUTH KOREA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 101. SOUTH KOREA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 102. SOUTH KOREA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 103. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 104. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 105. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 106. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 107. LAMEA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 108. LAMEA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 109. LAMEA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 110. LAMEA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 111. LAMEA NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 112. BRAZIL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 113. BRAZIL NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 114. BRAZIL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 115. BRAZIL NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 116. SAUDI ARABIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 117. SAUDI ARABIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 118. SAUDI ARABIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 119. SAUDI ARABIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 120. SOUTH AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 121. SOUTH AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 122. SOUTH AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 123. SOUTH AFRICA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 124. REST OF LAMEA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 125. REST OF LAMEA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
TABLE 126. REST OF LAMEA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
TABLE 127. REST OF LAMEA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 128.AB SCIEX LLC: COMPANY SNAPSHOT
TABLE 129.AB SCIEX LLC: OPERATING SEGMENTS
TABLE 130.AB SCIEX LLC: PRODUCT PORTFOLIO
TABLE 131.AB SCIEX LLC: NET SALES,
TABLE 132.AB SCIEX LLC: KEY STRATERGIES
TABLE 133.AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 134.AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS
TABLE 135.AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 136.AGILENT TECHNOLOGIES INC.: NET SALES,
TABLE 137.AGILENT TECHNOLOGIES INC.: KEY STRATERGIES
TABLE 138.BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
TABLE 139.BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
TABLE 140.BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 141.BIO-RAD LABORATORIES INC.: NET SALES,
TABLE 142.BIO-RAD LABORATORIES INC.: KEY STRATERGIES
TABLE 143.COVIDIEN PLC: COMPANY SNAPSHOT
TABLE 144.COVIDIEN PLC: OPERATING SEGMENTS
TABLE 145.COVIDIEN PLC: PRODUCT PORTFOLIO
TABLE 146.COVIDIEN PLC: NET SALES,
TABLE 147.COVIDIEN PLC: KEY STRATERGIES
TABLE 148.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 149.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 150.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 151.GE HEALTHCARE: NET SALES,
TABLE 152.GE HEALTHCARE: KEY STRATERGIES
TABLE 153.PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 154.PERKINELMER, INC.: OPERATING SEGMENTS
TABLE 155.PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 156.PERKINELMER, INC.: NET SALES,
TABLE 157.PERKINELMER, INC.: KEY STRATERGIES
TABLE 158.MASIMO CORPORATION: COMPANY SNAPSHOT
TABLE 159.MASIMO CORPORATION: OPERATING SEGMENTS
TABLE 160.MASIMO CORPORATION: PRODUCT PORTFOLIO
TABLE 161.MASIMO CORPORATION: NET SALES,
TABLE 162.MASIMO CORPORATION: KEY STRATERGIES
TABLE 163.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 164.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
TABLE 165.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 166.NATUS MEDICAL INCORPORATED: NET SALES,
TABLE 167.NATUS MEDICAL INCORPORATED: KEY STRATERGIES
TABLE 168.TRIVITRON HEALTHCARE: COMPANY SNAPSHOT
TABLE 169.TRIVITRON HEALTHCARE: OPERATING SEGMENTS
TABLE 170.TRIVITRON HEALTHCARE: PRODUCT PORTFOLIO
TABLE 171.TRIVITRON HEALTHCARE: NET SALES,
TABLE 172.TRIVITRON HEALTHCARE: KEY STRATERGIES
TABLE 173.WATERS CORPORATION: COMPANY SNAPSHOT
TABLE 174.WATERS CORPORATION: OPERATING SEGMENTS
TABLE 175.WATERS CORPORATION: PRODUCT PORTFOLIO
TABLE 176.WATERS CORPORATION: NET SALES,
TABLE 177.WATERS CORPORATION: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD22AU201 )"新生児スクリーニングのグローバル市場(2021~2031):器具、消耗品" (英文:Newborn Screening Market By Product Type (Instrument, Consumables), By Test Type (Blood test, Hearing screening test, Heart screening), By Technology (Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Others), By End User (Hospitals, Clinical laboratories): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。